Candidate gene study of macular response to supplemental lutein and zeaxanthin

Experimental Eye Research

Volumn 115, Issue , 2013, Pages 172-177

  Yonova Doing, Ekaterina ^a   Hysi, Pirro G ^a   Venturini, Cristina ^a,b   Williams, Katie M ^a   Nag, Abhishek ^a   Beatty, Stephen ^c   Liew, S H Melissa ^d   Gilbert, Clare E ^e   Hammond, Christopher J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Ireland   (Ireland)

^d NOVARTIS PHARMA AG   (Switzerland)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Genetics; Lutein; Macular degeneration; Macular pigment; Supplementation

Indexed keywords

ABC TRANSPORTER A1; ACYL COENZYME A DESATURASE 1; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ARTICLE; FATTY ACID METABOLISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

CAREDS; CAROTENOIDS IN AGE RELATED EYE DISEASE STUDY; GENETICS; L; LUTEIN; LUTEIN AND ZEAXANTHIN; LZ; MACULAR DEGENERATION; MACULAR PIGMENT; MACULAR PIGMENT OPTICAL DENSITY; MP; MPOD; SUPPLEMENTATION; Z; ZEAXANTHIN;

ADULT; ATP BINDING CASSETTE TRANSPORTER 1; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIS-TRANS-ISOMERASES; DIETARY SUPPLEMENTS; FATTY ACID DESATURASES; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; LUTEIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; QUANTITATIVE TRAIT, HERITABLE; RETINAL PIGMENTS; SCAVENGER RECEPTORS, CLASS B; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; XANTHOPHYLLS; YOUNG ADULT;

EID: 84882750014     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.07.020     Document Type: Article

References (48)

1. Andrew T., Hart D.J., Snieder H., de Lange M., Spector T.D., MacGregor A.J. Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res. 2001, 4:464-477.
2. AREDS2 Lutein+ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013, 309:2005-2015.
3. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45:115-134.
4. Chen Y., Buck J., Derguini F. Anhydroretinol induces oxidative stress and cell death. Cancer Res. 1999, 59:3985-3990.
5. Cipriani V., Leung H.T., Plagnol V., Bunce C., Khan J.C., Shahid H., Moore A.T., Harding S.P., Bishop P.N., Hayward C., Campbell S., Armbrecht A.M., Dhillon B., Deary I.J., Campbell H., Dunlop M., Dominiczak A.F., Mann S.S., Jenkins S.A., Webster A.R., Bird A.C., Lathrop M., Zelenika D., Souied E.H., Sahel J.A., Leveillard T., Cree A.J., Gibson J., Ennis S., Lotery A.J., Wright A.F., Clayton D.G., Yates J.R. Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3. Hum. Mol. Genet. 2012, 21:4138-4150.
6. Connolly E.E., Beatty S., Loughman J., Howard A.N., Louw M.S., Nolan J.M. Supplementation with all three macular carotenoids: response, stability, and safety. Invest. Ophthalmol. Vis. Sci. 2011, 52:9207-9217.
7. Connor W.E., Duell P.B., Kean R., Wang Y. The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter. Invest. Ophthalmol. Vis. Sci. 2007, 48:4226-4231.
8. Curcio C.A., Johnson M., Rudolf M., Huang J.D. The oil spill in ageing Bruch membrane. Br. J. Ophthalmol. 2011, 95:1638-1645.
9. Curran-Celentano J., Hammond B.R., Ciulla T.A., Cooper D.A., Pratt L.M., Danis R.B. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am. J. Clin. Nutr. 2001, 74:796-802.
10. Delcourt C., Carriere I., Delage M., Barberger-Gateau P., Schalch W. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest. Ophthalmol. Vis. Sci. 2006, 47:2329-2335.
11. Delyfer M.N., Buaud B., Korobelnik J.F., Rougier M.B., Schalch W., Etheve S., Vaysse C., Combe N., Goff M.L., Wolf-Schnurrbusch U.E., Wolf S., Barberger-Gateau P., Delcourt C. Association of macular pigment density with plasma omega-3 fatty acids: the PIMAVOSA study. Invest. Ophthalmol. Vis. Sci. 2012, 53:1204-1210.
12. Duncan K.G., Hosseini K., Bailey K.R., Yang H., Lowe R.J., Matthes M.T., Kane J.P., LaVail M.M., Schwartz D.M., Duncan J.L. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br. J. Ophthalmol. 2009, 93:1116-1120.
13. Evans J.R. Risk factors for age-related macular degeneration. Prog. Retin. Eye Res. 2001, 20:227-253.
14. Ferrucci L., Perry J.R., Matteini A., Perola M., Tanaka T., Silander K., Rice N., Melzer D., Murray A., Cluett C., Fried L.P., Albanes D., Corsi A.M., Cherubini A., Guralnik J., Bandinelli S., Singleton A., Virtamo J., Walston J., Semba R.D., Frayling T.M. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am. J. Hum. Genet. 2009, 84:123-133.
15. Friedman D.S., Katz J., Bressler N.M., Rahmani B., Tielsch J.M. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology 1999, 106:1049-1055.
16. Fritsche L.G., Chen W., Schu M., Yaspan B.L., Yu Y., Thorleifsson G., Zack D.J., Arakawa S., Cipriani V., Ripke S., Igo R.P., Buitendijk G.H., Sim X., Weeks D.E., Guymer R.H., Merriam J.E., Francis P.J., Hannum G., Agarwal A., Armbrecht A.M., Audo I., Aung T., Barile G.R., Benchaboune M., Bird A.C., Bishop P.N., Branham K.E., Brooks M., Brucker A.J., Cade W.H., Cain M.S., Campochiaro P.A., Chan C.C., Cheng C.Y., Chew E.Y., Chin K.A., Chowers I., Clayton D.G., Cojocaru R., Conley Y.P., Cornes B.K., Daly M.J., Dhillon B., Edwards A.O., Evangelou E., Fagerness J., Ferreyra H.A., Friedman J.S., Geirsdottir A., George R.J., Gieger C., Gupta N., Hagstrom S.A., Harding S.P., Haritoglou C., Heckenlively J.R., Holz F.G., Hughes G., Ioannidis J.P., Ishibashi T., Joseph P., Jun G., Kamatani Y., Katsanis N., Keilhauer C.N., Khan J.C., Kim I.K., Kiyohara Y., Klein B.E., Klein R., Kovach J.L., Kozak I., Lee C.J., Lee K.E., Lichtner P., Lotery A.J., Meitinger T., Mitchell P., Mohand-Said S., Moore A.T., Morgan D.J., Morrison M.A., Myers C.E., Naj A.C., Nakamura Y., Okada Y., Orlin A., Ortube M.C., Othman M.I., Pappas C., Park K.H., Pauer G.J., Peachey N.S., Poch O., Priya R.R., Reynolds R., Richardson A.J., Ripp R., Rudolph G., Ryu E., Sahel J.A., Schaumberg D.A., Scholl H.P., Schwartz S.G., Scott W.K., Shahid H., Sigurdsson H., Silvestri G., Sivakumaran T.A., Smith R.T., Sobrin L., Souied E.H., Stambolian D.E., Stefansson H., Sturgill-Short G.M., Takahashi A., Tosakulwong N., Truitt B.J., Tsironi E.E., Uitterlinden A.G., van Duijn C.M., Vijaya L., Vingerling J.R., Vithana E.N., Webster A.R., Wichmann H.E., Winkler T.W., Wong T.Y., Wright A.F., Zelenika D., Zhang M., Zhao L., Zhang K., Klein M.L., Hageman G.S., Lathrop G.M., Stefansson K., Allikmets R., Baird P.N., Gorin M.B., Wang J.J., Klaver C.C., Seddon J.M., Pericak-Vance M.A., Iyengar S.K., Yates J.R., Swaroop A., Weber B.H., Kubo M., Deangelis M.M., Leveillard T., Thorsteinsdottir U., Haines J.L., Farrer L.A., Heid I.M., Abecasis G.R. Seven new loci associated with age-related macular degeneration. Nat. Genet. 2013, 45:433-439.
17. Hammond B.R., Curran-Celentano J., Judd S., Fuld K., Krinsky N.I., Wooten B.R., Snodderly D.M. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vis. Res. 1996, 36:2001-2012.
18. Hammond C.J., Liew S.H., Van Kuijk F.J., Beatty S., Nolan J.M., Spector T.D., Gilbert C.E. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study. Invest. Ophthalmol. Vis. Sci. 2012, 53:4963-4968.
19. Howie B.N., Donnelly P., Marchini J. Aflexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009, 5:e1000529.
20. Hyman L., Schachat A.P., He Q., Leske M.C. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-related Macular Degeneration Risk Factors Study Group. Arch. Ophthalmol. 2000, 118:351-358.
21. Johnson E.J. Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr. Rev. 2005, 63:9-15.
22. Kawasaki R., Yasuda M., Song S.J., Chen S.J., Jonas J.B., Wang J.J., Mitchell P., Wong T.Y. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2010, 117:921-927.
23. Kim S.R., Nakanishi K., Itagaki Y., Sparrow J.R. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp. Eye Res. 2006, 82:828-839.
24. Klamt F., Dal-Pizzol F., Roehrs R., de Oliveira R.B., Dalmolin R., Henriques J.A., de Andrades H.H., de Paula Ramos A.L., Saffi J., Moreira J.C. Genotoxicity, recombinogenicity and cellular preneoplasic transformation induced by vitamin A supplementation. Mutat. Res. 2003, 539:117-125.
25. Kobayashi T., Zadravec D., Jacobsson A. ELOVL2 overexpression enhances triacylglycerol synthesis in 3T3-L1 and F442A cells. FEBS Lett. 2007, 581:3157-3163.
26. Kopplin L.J., Igo R.P., Wang Y., Sivakumaran T.A., Hagstrom S.A., Peachey N.S., Francis P.J., Klein M.L., SanGiovanni J.P., Chew E.Y., Pauer G.J., Sturgill G.M., Joshi T., Tian L., Xi Q., Henning A.K., Lee K.E., Klein R., Klein B.E., Iyengar S.K. Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration. Genes Immun. 2010, 11:609-621.
27. Kostic D., White W.S., Olson J.A. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am. J. Clin. Nutr. 1995, 62:604-610.
28. Liew S.H., Gilbert C.E., Spector T.D., Mellerio J., Marshall J., van Kuijk F.J., Beatty S., Fitzke F., Hammond C.J. Heritability of macular pigment: a twin study. Invest. Ophthalmol. Vis. Sci. 2005, 46:4430-4436.
29. Lobo G.P., Amengual J., Palczewski G., Babino D., von Lintig J. Mammalian carotenoid-oxygenases: key players for carotenoid function and homeostasis. Biochim. Biophys. Acta 2012, 1821:78-87.
30. Margrain T.H., Boulton M., Marshall J., Sliney D.H. Do blue light filters confer protection against age-related macular degeneration?. Prog. Retin. Eye Res. 2004, 23:523-531.
31. McCarty C.A., Mukesh B.N., Fu C.L., Mitchell P., Wang J.J., Taylor H.R. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch. Ophthalmol. 2001, 119:1455-1462.
32. McKay G.J., Loane E., Nolan J.M., Patterson C.C., Meyers K.J., Mares J.A., Yonova-Doing E., Hammond C.J., Beatty S., Silvestri G. Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids. Ophthalmology 2013, 10.1016/j.ophtha.2013.01.030.
33. Meyers K.J., Johnson E.J., Bernstein P.S., Iyengar S.K., Engelman C.D., Karki C.K., Liu Z., Igo R.P., Truitt B., Klein M.L., Snodderly D.M., Blodi B.A., Gehrs K.M., Sarto G.E., Wallace R.B., Robinson J., Leblanc E.S., Hageman G., Tinker L., Mares J.A. Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study. Invest. Ophthalmol. Vis. Sci. 2013, 54:2333-2345.
34. Mullins R.F., Russell S.R., Anderson D.H., Hageman G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000, 14:835-846.
35. Murata M., Kawanishi S. Oxidative DNA damage by vitamin A and its derivative via superoxide generation. J.Biol. Chem. 2000, 275:2003-2008.
36. Rudnicka A.R., Jarrar Z., Wormald R., Cook D.G., Fletcher A., Owen C.G. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 2012, 119:571-580.
37. Schmitz G., Langmann T. Structure, function and regulation of the ABC1 gene product. Curr. Opin. Lipidol. 2001, 12:129-140.
38. Siems W., Sommerburg O., Schild L., Augustin W., Langhans C.D., Wiswedel I. Beta-carotene cleavage products induce oxidative stress invitro by impairing mitochondrial respiration. FASEB J. 2002, 16:1289-1291.
39. Smith W., Assink J., Klein R., Mitchell P., Klaver C.C., Klein B.E., Hofman A., Jensen S., Wang J.J., de Jong P.T. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001, 108:697-704.
40. Tanaka T., Shen J., Abecasis G.R., Kisialiou A., Ordovas J.M., Guralnik J.M., Singleton A., Bandinelli S., Cherubini A., Arnett D., Tsai M.Y., Ferrucci L. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet. 2009, 5:e1000338.
41. Thurnham D.I., Tremel A., Howard A.N. Asupplementation study in human subjects with a combination of meso-zeaxanthin, (3R,3'R)-zeaxanthin and (3R,3'R,6'R)-lutein. Br. J. Nutr. 2008, 100:1307-1314.
42. Wang Y., Roger Illingworth D., Connor S.L., Barton Duell P., Connor W.E. Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene. Eur. J. Nutr. 2010, 49:327-336.
43. Wolf-Schnurrbusch U.E., Roosli N., Weyermann E., Heldner M.R., Hohne K., Wolf S. Ethnic differences in macular pigment density and distribution. Invest. Ophthalmol. Vis. Sci. 2007, 48:3783-3787.
44. Woo G.C., Lee M.H. Are ethnic differences in the F-M 100 scores related to macular pigmentation?. Clin. Exp. Optom. 2002, 85:372-377.
45. Xue L., Gollapalli D.R., Maiti P., Jahng W.J., Rando R.R. Apalmitoylation switch mechanism in the regulation of the visual cycle. Cell 2004, 117:761-771.
46. Yu Y., Bhangale T.R., Fagerness J., Ripke S., Thorleifsson G., Tan P.L., Souied E.H., Richardson A.J., Merriam J.E., Buitendijk G.H., Reynolds R., Raychaudhuri S., Chin K.A., Sobrin L., Evangelou E., Lee P.H., Lee A.Y., Leveziel N., Zack D.J., Campochiaro B., Campochiaro P., Smith R.T., Barile G.R., Guymer R.H., Hogg R., Chakravarthy U., Robman L.D., Gustafsson O., Sigurdsson H., Ortmann W., Behrens T.W., Stefansson K., Uitterlinden A.G., van Duijn C.M., Vingerling J.R., Klaver C.C., Allikmets R., Brantley M.A., Baird P.N., Katsanis N., Thorsteinsdottir U., Ioannidis J.P., Daly M.J., Graham R.R., Seddon J.M. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum. Mol. Genet. 2011, 20:3699-3709.
47. Zerbib J., Seddon J.M., Richard F., Reynolds R., Leveziel N., Benlian P., Borel P., Feingold J., Munnich A., Soubrane G., Kaplan J., Rozet J.M., Souied E.H. rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One 2009, 4:e7341.
48. Zhou J., Jang Y.P., Kim S.R., Sparrow J.R. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16182-16187.